Navigation Links
HIV positive and HIV negative patients have similar survival rates following liver transplant
Date:4/24/2009

Copenhagen, Denmark, Friday 24 April: HIV positive and HIV negative patients have comparable survival rates following liver transplant, according to new research presented today at EASL 2009, the Annual Meeting of the European Association for the Study of Liver in Copenhagen, Denmark.

The study results showed no difference in survival rates at 1 and 5 years between HIV negative and HIV positive patients (86.5% and 74% versus 87.1% and 78%, p=0.843), suggesting a good prognosis for HIV positive patients following liver transplant. However, the study confirmed that co-infection with hepatitis C virus (HCV) is a significant predictor of poorer survival rates in patients with HIV. Survival rates at 1 and 5 years were 73% and 53% in HIV positive patients with hepatitis C versus 87% and 69% (p=0.047) in HIV negative patients with hepatitis C.

Doctor Kosh Agarwal, of the Institute of Liver Studies, Kings College Hospital, London, who led the study said: "Data on long term outcomes from liver transplantation in HIV patients is limited. These study results are valuable confirmation that selected HIV positive patients are as suitable candidates for liver transplant as HIV negative patients and should have similar access to treatment. However, those patients with co-infection with hepatitis C did less well, emphasising the need for appropriate antiviral therapy early in the course of their HCV related liver disease. In the context of co-infection, these data emphasise the need to develop newer and more innovative treatment strategies. These should include exposure to new small molecule therapies for HCV that are currently being explored in mono-infection."

The researchers conducted a prospective analysis of the UK Transplant Database to determine the long-term outcomes in HIV patients undergoing liver transplant in the UK. They examined 6,315 adult patients (>18 years) undergoing their first liver transplant between March 1994 and April 2008
'/>"/>

Contact: Camilla Dormer
easlpressoffice@cohnwolfe.com
44-078-761-90439
European Association for the Study of the Liver
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. The ALS Association's 'ALS Across America' Focuses On Staying Positive and Involved
2. Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide
3. Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints
4. Economy Got You Down? Use The Principles Of Positive Psychology
5. Standard and Poors Raises Boston Scientifics Rating Outlook to Positive
6. Recent Industry Developments Reaffirm Positive Glucose Industry Outlook
7. Cepheid Receives Health Canada License for First On-demand Diagnostic Test for Life-threatening MRSA and S. aureus Infections From Patient Positive Blood Culture Bottles
8. Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures
9. Prescription Copay Assistance for Patients taking Gleevec or Tasigna for Philadelphia chromosome-positive Chronic Myelogenous Leukemia (Ph+ CML)
10. Positive behavior support training curriculum
11. CONBRIZA Receives Positive CHMP Opinion for the Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Adam DreamHealer’s Glo...aling intentions changes the physiology of someone...ing intentions at a time unknown to a volunteer wh...s analyzed by world experts in the USA and Canada....November 25, 2009 -- Adam DreamHealer’s Gl...
(Date:11/25/2009)... Vintners and guests, generos..., Hillsboro, OR (PRWEB) No...! The Oregon Pinot Noir Auction topped $607,700 ...November 13 and 14. Spurred by the Big Board aucti...raised close to $14,000 above 2008 totals, over 40...
(Date:11/25/2009)..., LONDON,November25/PRNewswire/--Therearemanyway...angivebigresults.Butthere,alwaysseemstobeconflicti...toimproveourhealth. , So,therealbuzz.comteamh...evetobeprettymuchincontrovertible!Doingacombinatio...proveyourlifestyle,andwell-being-sotrythemout. ,...
(Date:11/24/2009)...-call radiology residents generally provide accura...diology CT scans after hours when attending neuror...large study performed at a level I trauma center p...the American College of Radiology ( JACR ). , ...ssential element of diagnostic radiology. In most ...
(Date:11/24/2009)..., OXFORD,EnglandandSANDIEGO,Nov.24/PRNewswire/--...of-caremoleculardiagnosticscompany,announcedtodayf..., Dr.JorgeGarceswillleadtheUSteamasPresidentand...inancialOfficer,USA.StationedatEnigma,snewU.S.head...xpandrapidlywitharecruitmentprogrammeplannedforass...
Breaking Medicine News(10 mins):Health News:Intriguing Scientific Results from World's Largest Intention Healing Project: DreamHealer 2Health News:Salud! The Oregon Pinot Noir Auction Raises Over $607,000 2Health News:Salud! The Oregon Pinot Noir Auction Raises Over $607,000 3Health News:realbuzz.com - Top 25 Ways to Improve Your Health & get a Better Sex Life! 2Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 2Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 3
...ps patients with bladder cancer live longer, accor...ho receive chemotherapy plus surgery //survive lon...all this an important advance in the treatment of ... Cancer Society, approximately 57,000 people will ...
...ay want to leave the alcohol at home next time you...unburn.Researchers found those who consumed //alco...drinkers and were more likely to need a pain relie...rs. However, drinkers did not report spending more...
...ty should be the treatment of choice for heart att...//go to doesn't offer angioplasty services and the...reatment. Research has shown heart attack patie...ot-busting drug therapy called fibrinolysis. Da...
...f heart disease may be present early in life, say ...between body mass index and C-reactive //protein l...r for cardiovascular disease in adults. Resea...l S. Ford, M.D., M.P.H., from the Centers for Dise...
...rt taking painkillers during pregnancy increases t...atory drugs, which include// aspirin and ibuprofen...ften used by pregnant women. Doctors interview...e pregnant, reproductive history, and potential ri...
...earchers say giving heroin to opiate addicts can h...archers in the Netherlands conducted two separate ...t respond to methadone maintenance treatment. Part...er 12 months of methadone treatment alone, 12 mont...
Other Medicine News:
(Date:11/24/2009)...iencesCorporationannouncedtodaythattherewillbemult...ationFLT3inhibitor,inAMLatthe51stAmericanSocietyof...A,December5-8,2009.Anoralpresentationwillhighlight...ystudyinadultswithacutemyeloidleukemia(AML).Additi...eeffectofAC220monotherapyandincombinationwithchemo...
(Date:11/24/2009)...irstCall/--CardioGenicsHoldingsInc.(OTCBulletinBoa...gtheimmunoassaysegmentoftheIVDtestingmarket,report...tothenextphaseofthecommercializationofCardioGenics.... ,, PertheagreementwithMerckChimiethatwasexecu...withitsproprietarysilvercoatedparamagneticbeadsfor...
(Date:11/24/2009)...all/--EchoTherapeutics,Inc.(OTCBulletinBoard:ECTE)...ystemasanon-invasive,wireless,transdermalcontinuou...nPrepSystemfortransdermaldrugdelivery,announcedtod...veOfficer,willpresentatthe13thAnnualBiotechandSpec...rkSocietyofSecuritiesAnalysts,at2:05onDecember1,20...
Breaking Medicine Technology:Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 3Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2Does Diabetes Slow Alzheimers 3F 60110 1Does Diabetes Slow Alzheimers 3F 60110 2Heart Disease Gender Gap Narrows 60108 1Heart Disease Gender Gap Narrows 60108 2Heart Disease Gender Gap Narrows 60108 3Deadly stomach infection rising in community settings Mayo Clinic study finds 60106 1Deadly stomach infection rising in community settings Mayo Clinic study finds 60106 2
...c. 2 A study has found that positron emission mam...east, is not affected by either breast density or ...the effectiveness of standard mammography and MRI ...ay at the annual meeting of the Radiological Socie... of PEM to detect cancer does not appear to be adv...
...Pte Ltd today announced the initiation of a Phase ...active JAK2 inhibitor, in leading medical centers ...myelofibrosis (CIMF). , , The trial is desig...518 in patients with CIMF and is expected to enrol... will assess the safety profile and evaluate the p...
Other Medicine Technology:New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3